OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Backes on Toxicity Considerations With PARP Inhibitors in Ovarian Cancer

January 23rd 2020

Floor J. Backes, MD, discusses toxicity considerations with PARP inhibitors in ovarian cancer.

Dr. Wong on Antibody-Drug Conjugate Research in Multiple Myeloma

January 23rd 2020

Sandy Wong, MD, discusses the ongoing research of antibody-drug conjugates in multiple myeloma.

Dr. Gibbs on Testing for p16 and p21 in Osteosarcoma

January 23rd 2020

C. Parker Gibbs Jr, MD, discusses how to test for p16 and p21 in patients with osteosarcoma.

Dr. Abou-Alfa on Ramucirumab as Second-Line Therapy for Hepatocellular Carcinoma

January 23rd 2020

Ghassan K. Abou-Alfa, MD, discusses the role of ramucirumab in the treatment of patients with hepatocellular carcinoma in the second-line setting.

Dr. Ramakrishnan on Benefit of CAR T-Cell Therapy in MCL

January 22nd 2020

Praveen Ramakrishnan, MD, discusses the benefit of CAR T-cell therapy in patients with mantle cell lymphoma.

Dr. Sharman on the Design of the ELEVATE-TN Trial in CLL

January 22nd 2020

Jeff Sharman, MD, discusses the design of the phase III ELEVATE-TN trial in patients with previously untreated chronic lymphocytic leukemia.

Dr. Zhu on Mitigating Toxicities of Elective Nodal Irradiation in Breast Cancer

January 22nd 2020

He James Zhu, MD, PhD, discusses potential strategies to mitigate the toxicities of elective nodal irradiation in breast cancer.

Dr. Herbst on Combination of Nivolumab and Ipilimumab in Patients With NSCLC

January 22nd 2020

Roy S. Herbst, MD, PhD, discusses the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in patients with advanced non–small-cell lung cancer (NSCLC).

Dr. Norden on Cost and Effectiveness of Genomic Testing

January 22nd 2020

Andrew Norden, MD, MPH, MBA, chief medical officer, Cota, discusses concerns surrounding cost and efficacy of molecular testing.

Dr. Anderson on Recent FDA Approvals in Multiple Myeloma

January 22nd 2020

Larry Anderson, MD, PhD, discusses recent FDA approvals in multiple myeloma.

Dr. Nagalla on the Utility of DOACs in MPN-Associated Thrombosis

January 22nd 2020

Srikanth Nagalla, MD, discusses the utility of direct oral anticoagulants in patients with a myeloproliferative neoplasm–associated venous thromboembolism.

Dr. Ribeiro on the Role of Surgery in Pancreatic Cancer

January 22nd 2020

Afonso Ribeiro, MD, discusses the role of surgery in treating patients with pancreatic cancer.

Dr. Alva on TKI Monotherapy and Combinations for RCC

January 22nd 2020

Ajjai Shivaram Alva, MBBS, discusses TKI monotherapy and in combination with immunotherapy for patients with renal cell carcinoma.

Dr. Mims on the Emergence of Targeted Therapy in AML

January 22nd 2020

Alice S. Mims, MD, discusses the emergence of targeted therapy in acute myeloid leukemia treatment.

Dr. Coleman on Implications of the VELIA Trial in Ovarian Cancer

January 21st 2020

Robert L. Coleman, MD, FACOG, FACS, professor and Ann Rife Cox Chair in Gynecology, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses the implications of the phase III VELIA trial in ovarian cancer.

Dr. Sparano on the Utility of Liquid Biopsies in Breast Cancer

January 21st 2020

Joseph A. Sparano, MD, associate director for clinical research, Albert Einstein Cancer Center, professor of Medicine & Obstetrics, Gynecology, and Women’s Health at the Albert Einstein College of Medicine, and associate chairman for Clinical Research in the Department of Oncology at Montefiore Medical Center, discusses the utility of liquid biopsies in breast cancer.

Dr. Koo on Metastasis-Directed Therapy in Prostate Cancer

January 21st 2020

Phillip J. Koo, MD, division chief of Diagnostic Imaging, Banner MD Anderson Cancer Center, discusses the use of metastasis-directed therapy in prostate cancer.

Dr. Kasi on Utility of Personalized Medicine in Colorectal Cancer

January 21st 2020

Pashtoon M. Kasi, MD, discusses the recycling of therapies in patients with colorectal cancer (CRC).

Dr. Moore on Benefit of Mirvetuximab Soravtansine in Ovarian Cancer

January 21st 2020

Kathleen Moore, MD, discusses the benefit of mirvetuximab soravtansine in patients with platinum-resistant ovarian cancer.

Dr. Choti on Future Treatment of Patients With Stage IV Pancreatic Cancer

January 21st 2020

Michael A. Choti, MD, discusses the future of treatment for patients with stage IV pancreatic cancer.